Login to Your Account



Other News To Note


Friday, July 15, 2011
Impax Pharmaceuticals, of Hayward, Calif., received an award of up to $400,000 from The Michael J. Fox Foundation for development of its Parkinson's candidate, IPX066, an extended-release carbidopa-levodopa product. The funding will support a study of dosing conversion from CD-LD to IPX066 and an open-label extension safety study.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription